424 related articles for article (PubMed ID: 26902609)
1. Impact of estrogen receptor-β expression on breast cancer prognosis: a meta-analysis.
Liu J; Guo H; Mao K; Zhang K; Deng H; Liu Q
Breast Cancer Res Treat; 2016 Feb; 156(1):149-62. PubMed ID: 26902609
[TBL] [Abstract][Full Text] [Related]
2. The Prognostic Value of Forkhead Box P3 Expression in Operable Breast Cancer: A Large-Scale Meta-Analysis.
Lin SC; Gan ZH; Yao Y; Min da L
PLoS One; 2015; 10(8):e0136374. PubMed ID: 26305693
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor beta as a prognostic factor in breast cancer patients: A systematic review and meta-analysis.
Tan W; Li Q; Chen K; Su F; Song E; Gong C
Oncotarget; 2016 Mar; 7(9):10373-85. PubMed ID: 26863572
[TBL] [Abstract][Full Text] [Related]
4. TIF1γ interferes with TGFβ1/SMAD4 signaling to promote poor outcome in operable breast cancer patients.
Kassem L; Deygas M; Fattet L; Lopez J; Goulvent T; Lavergne E; Chabaud S; Carrabin N; Chopin N; Bachelot T; Gillet G; Treilleux I; Rimokh R
BMC Cancer; 2015 Jun; 15():453. PubMed ID: 26040677
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of neutrophil-to-lymphocyte ratio in breast cancer: a systematic review and meta-analysis.
Ethier JL; Desautels D; Templeton A; Shah PS; Amir E
Breast Cancer Res; 2017 Jan; 19(1):2. PubMed ID: 28057046
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and clinical significance of syndecan-1 expression in breast cancer: A systematic review and meta-analysis.
Qiao W; Liu H; Guo W; Li P; Deng M
Eur J Surg Oncol; 2019 Jul; 45(7):1132-1137. PubMed ID: 30598194
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
8. Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.
Vera-Badillo FE; Templeton AJ; de Gouveia P; Diaz-Padilla I; Bedard PL; Al-Mubarak M; Seruga B; Tannock IF; Ocana A; Amir E
J Natl Cancer Inst; 2014 Jan; 106(1):djt319. PubMed ID: 24273215
[TBL] [Abstract][Full Text] [Related]
9. Poor prognosis of single hormone receptor- positive breast cancer: similar outcome as triple-negative breast cancer.
Bae SY; Kim S; Lee JH; Lee HC; Lee SK; Kil WH; Kim SW; Lee JE; Nam SJ
BMC Cancer; 2015 Mar; 15():138. PubMed ID: 25880075
[TBL] [Abstract][Full Text] [Related]
10. The impact of chemokine receptor CXCR4 on breast cancer prognosis: a meta-analysis.
Xu TP; Shen H; Liu LX; Shu YQ
Cancer Epidemiol; 2013 Oct; 37(5):725-31. PubMed ID: 23763828
[TBL] [Abstract][Full Text] [Related]
11. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
12. Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast.
Honma N; Saji S; Kurabayashi R; Aida J; Arai T; Horii R; Akiyama F; Iwase T; Harada N; Younes M; Toi M; Takubo K; Sakamoto G
APMIS; 2008 Oct; 116(10):923-30. PubMed ID: 19132986
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of ER-α, ER-Β1 and ER-Β2 expression and correlation with clinicopathologic factors in invasive luminal subtype breast cancers.
Zhang H; Zhang Z; Xuan L; Zheng S; Guo L; Zhan Q; Qu X; Zhang B; Wang Y; Wang X; Song Y
Clin Transl Oncol; 2012 Mar; 14(3):225-31. PubMed ID: 22374427
[TBL] [Abstract][Full Text] [Related]
14. The impact of IGF-1R expression on the outcomes of patients with breast cancer: a meta-analysis.
Yan S; Jiao X; Li K; Li W; Zou H
Onco Targets Ther; 2015; 8():279-87. PubMed ID: 25674003
[TBL] [Abstract][Full Text] [Related]
15. Expression of voltage-gated sodium channel Nav1.5 in non-metastatic colon cancer and its associations with estrogen receptor (ER)-β expression and clinical outcomes.
Peng J; Ou Q; Wu X; Zhang R; Zhao Q; Jiang W; Lu Z; Wan D; Pan Z; Fang Y
Chin J Cancer; 2017 Nov; 36(1):89. PubMed ID: 29122010
[TBL] [Abstract][Full Text] [Related]
16. Survival and disease-free benefits with mastectomy versus breast conservation therapy for early breast cancer: a meta-analysis.
Chen Y; Jiang L; Gao B; Cheng ZY; Jin J; Yang KH
Breast Cancer Res Treat; 2016 Jun; 157(3):517-25. PubMed ID: 27246814
[TBL] [Abstract][Full Text] [Related]
17. Indispensability of chemotherapy in estrogen receptor-negative early breast cancer in elderly women with diabetes mellitus.
Jia X; Hong Q; Cheng J; Li J; Wang Y; Mo M; Shao Z; Shen Z; Liu G
Diabetes Technol Ther; 2015 Apr; 17(4):248-54. PubMed ID: 25781236
[TBL] [Abstract][Full Text] [Related]
18. Prognostic and clinicopathological value of Twist expression in breast cancer: A meta-analysis.
Qiao W; Jia Z; Liu H; Liu Q; Zhang T; Guo W; Li P; Deng M; Li S
PLoS One; 2017; 12(10):e0186191. PubMed ID: 29016671
[TBL] [Abstract][Full Text] [Related]
19. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor receptor overexpression and outcomes in early breast cancer: A systematic review and a meta-analysis.
Gonzalez-Conchas GA; Rodriguez-Romo L; Hernandez-Barajas D; Gonzalez-Guerrero JF; Rodriguez-Fernandez IA; Verdines-Perez A; Templeton AJ; Ocana A; Seruga B; Tannock IF; Amir E; Vera-Badillo FE
Cancer Treat Rev; 2018 Jan; 62():1-8. PubMed ID: 29126017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
